The Network is pleased to announce that following a network-wide Call for Nominations and unanimous support from CanVECTOR's Scientific Steering Committee (SSC), Dr. Grégoire Le Gal has been elected as the incoming CanVECTOR Co-Director beginning on August 1st, 2022.
Dr. Le Gal is a Professor in the Division of Hematology of the Department of Medicine at the University of Ottawa, a physician in the Thrombosis Program, Division of Hematology at The Ottawa Hospital, and a Senior Scientist in the Ottawa Hospital Research Institute, Clinical Epidemiology Program.
Dr. Le Gal has been an instrumental figure within the Network since its inception in 2015 as a Co-Lead of the Clinical Trials & Shared Platforms platform, SSC member, Clinical Investigators' Group (CIG) member, principal investigator on several network-related studies, and a CanVECTOR representative in the International Network of Venous Thromboembolism Clinical Research Networks (INVENT).
Dr. Le Gal will work alongside Dr. Susan Kahn as Co-Directors to continue to grow the network and ensure its long-term sustainability. A large part of CanVECTOR’s success lies in having a highly qualified leadership team. Dr. Kahn, SSC members, and staff are thrilled to welcome Dr. Le Gal to this new role.
And lastly, we want to thank Dr. Marc Rodger for his incredible and important leadership as Co-Director since CanVECTOR's inception. We wish him the best!
Important Note: Open Co-Lead Position, Clinical Trials and Shared Platforms platform
The Co-Lead position of the Clinical Trials & Shared Platforms platform will be vacant as of August 1st, 2022. CanVECTOR will hold an election to fill this position. Stay tuned for complete details.
Should you have any questions about this process, please email info@canvector.ca.
Thank you
Agnes Lee, MD, MSc, FRCPC
CanVECTOR SSC Elections Chair